title: In rectal cancer, the type of desmoplastic response after preoperative chemoradiotherapy is associated with prognosis.
abstract: Although the essential contribution of the desmoplastic reaction (DR) to aggressive tumor behavior is increasingly recognized, its prognostic value has not been investigated in rectal cancer after preoperative chemoradiotherapy. We retrospectively analyzed 101 consecutive patients with rectal cancer treated with short-course chemoradiotherapy followed by surgery (2001-2007). The DR in the resected primary tumor was pathologically classified into three patterns on the basis of products of cancer-associated fibroblasts (CAFs): mature (multilayered fibrotic), intermediate (keloid-like hyalinized), and immature (mostly myxoid). We classified 46 tumors as mature, 30 as intermediate, and 25 as immature DR. In addition, immunostaining of CD8(+) and FoxP3(+) cells was performed to characterize the immune response accompanying DR. Mature DR correlated with higher density of CD8(+) and FoxP3(+) cells in both resected surgical and pretreatment biopsy specimens. A significant association with DR category was observed for T stage, lymphatic invasion, and venous invasion (P ≤ 0.0001-0.0006). Mature DR was significantly associated with higher grade of pathological response (P = 0.0350). The 5-year disease-free survival (DFS) rates were 82, 72, and 47 % for mature, intermediate, and immature DR, respectively (P = 0.0055). On multivariate analysis, DR category and ypN were independently predictive of DFS. The pattern of the DR in rectal cancers after chemoradiotherapy treatment might have a prognostic value, as it likely reflects pretreatment desmoplastic environment.
authors.affiliation: Department of Surgery, National Defense Medical College, 3-2, Namiki, Tokorozawa, Saitama, 359-8513, Japan, ueno@ndmc.ac.jp.
authors.forename: Hideki
authors.initials: H
authors.lastname: Ueno
authors.forename: Eiji
authors.initials: E
authors.lastname: Shinto
authors.forename: Yojiro
authors.initials: Y
authors.lastname: Hashiguchi
authors.forename: Hideyuki
authors.initials: H
authors.lastname: Shimazaki
authors.forename: Yoshiki
authors.initials: Y
authors.lastname: Kajiwara
authors.forename: Takahiro
authors.initials: T
authors.lastname: Sueyama
authors.forename: Junji
authors.initials: J
authors.lastname: Yamamoto
authors.forename: Kazuo
authors.initials: K
authors.lastname: Hase
mesh_terms: D000230:Adenocarcinoma / Q000401:mortality* / Q000473:pathology* / Q000628:therapy*; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D059248:Chemoradiotherapy; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D053208:Kaplan-Meier Estimate; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D016016:Proportional Hazards Models; D012004:Rectal Neoplasms / Q000401:mortality* / Q000473:pathology* / Q000628:therapy*
references.citation: J Clin Oncol. 2006 Oct 1;24(28):4620-5
references.pmid: 17008704
references.citation: Ann Surg Oncol. 2012 Apr;19(4):1213-21
references.pmid: 21935746
references.citation: Oral Oncol. 2012 Jul;48(7):594-601
references.pmid: 22356894
references.citation: Eur J Cancer. 2011 May;47(8):1138-45
references.pmid: 21220198
references.citation: Dis Colon Rectum. 2013 Sep;56(9):1093-101
references.pmid: 23929020
references.citation: J Clin Oncol. 2009 Nov 1;27(31):5124-30
references.pmid: 19770376
references.citation: Ann Surg Oncol. 2011 Nov;18(12):3271-7
references.pmid: 21537868
references.citation: Br J Cancer. 2014 Mar 18;110(6):1595-605
references.pmid: 24504370
references.citation: N Engl J Med. 2006 Sep 14;355(11):1114-23
references.pmid: 16971718
references.citation: Cancer. 2011 Aug 15;117(16):3713-22
references.pmid: 21328329
references.citation: Dis Colon Rectum. 2011 Sep;54(9):1098-106
references.pmid: 21825889
references.citation: Colorectal Dis. 2008 Jul;10(6):563-8
references.pmid: 18070184
references.citation: J Pathol. 2011 Jan;223(2):162-76
references.pmid: 21125673
references.citation: J Clin Pathol. 1986 Jun;39(6):585-9
references.pmid: 3722412
references.citation: Ann Surg Oncol. 2014 Jun;21 Suppl 3:S414-21
references.pmid: 24566864
references.citation: Drug Resist Updat. 2013 Feb-Apr;16(1-2):10-21
references.pmid: 23434004
references.citation: Cancer. 2002 Feb 15;94(4):1121-30
references.pmid: 11920483
references.citation: Dis Colon Rectum. 2009 Jun;52(6):1137-43
references.pmid: 19581858
references.citation: Int J Cancer. 1999 May 17;81(4):629-36
references.pmid: 10225455
references.citation: Ann Surg Oncol. 2013 Apr;20(4):1179-84
references.pmid: 23328971
references.citation: Histopathology. 2002 Apr;40(4):327-34
references.pmid: 11943016
references.citation: Am J Surg Pathol. 2004 Feb;28(2):215-23
references.pmid: 15043311
references.citation: Cell Stem Cell. 2008 Jun 5;2(6):511-2
references.pmid: 18522839
references.citation: Br J Cancer. 2014 Nov 25;111(11):2082-90
references.pmid: 25247323
references.citation: Nat Rev Cancer. 2008 Jul;8(7):545-54
references.pmid: 18511937
references.citation: Int J Radiat Biol. 2007 Nov-Dec;83(11-12):733-41
references.pmid: 17852559
references.citation: Pathol Int. 2009 Dec;59(12):857-62
references.pmid: 20021610
references.citation: N Engl J Med. 2004 Oct 21;351(17):1731-40
references.pmid: 15496622
references.citation: J Pathol. 1997 Jul;182(3):318-24
references.pmid: 9349235
references.citation: Cancer Lett. 2013 Sep 10;338(1):120-6
references.pmid: 22546285
references.citation: Gut. 2004 Apr;53(4):581-6
references.pmid: 15016755
references.citation: Br J Surg. 2014 Jan;101(2):133-42
references.pmid: 24375303
references.citation: Ann Surg Oncol. 2015 May;22(5):1504-12
references.pmid: 25395146
references.citation: Ann Surg. 2010 Dec;252(6):998-1004
references.pmid: 21107110
references.citation: Int J Radiat Oncol Biol Phys. 2010 Jul 15;77(4):1158-65
references.pmid: 19800178
references.citation: Breast Cancer Res Treat. 2014 Dec;148(3):525-34
references.pmid: 25395319